https://scholars.lib.ntu.edu.tw/handle/123456789/633540
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Xu, Binghe | en_US |
dc.contributor.author | Hu, Xichun | en_US |
dc.contributor.author | Li, Wei | en_US |
dc.contributor.author | Sun, Tao | en_US |
dc.contributor.author | Shen, Kunwei | en_US |
dc.contributor.author | Wang, Shusen | en_US |
dc.contributor.author | Cheng, Ying | en_US |
dc.contributor.author | Zhang, Qingyuan | en_US |
dc.contributor.author | Cui, Shude | en_US |
dc.contributor.author | Tong, Zhongsheng | en_US |
dc.contributor.author | Geng, Cuizhi | en_US |
dc.contributor.author | Song, Erwei | en_US |
dc.contributor.author | CHIUN-SHENG HUANG | en_US |
dc.contributor.author | et al., | en_US |
dc.date.accessioned | 2023-07-12T06:33:30Z | - |
dc.date.available | 2023-07-12T06:33:30Z | - |
dc.date.issued | 2022-11 | - |
dc.identifier.issn | 09598049 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/633540 | - |
dc.description.abstract | The cyclin-dependent kinase 4/6 inhibitor palbociclib has demonstrated efficacy and a manageable safety profile in combination with endocrine therapy in women with oestrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) in international phase 3 trials. The phase 3 PALOMA-4 trial evaluated the efficacy and safety of palbociclib plus letrozole versus placebo plus letrozole in Asian women with ER+/HER2- ABC. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | European journal of cancer (Oxford, England : 1990) | en_US |
dc.subject | Advanced breast cancer; Asian; Letrozole; Oestrogen receptor–positive; Palbociclib | en_US |
dc.title | Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: Primary results from PALOMA-4 | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.ejca.2022.08.012 | - |
dc.identifier.pmid | 36155117 | - |
dc.identifier.scopus | 2-s2.0-85138510141 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85138510141 | - |
dc.relation.journalvolume | 175 | en_US |
dc.relation.pageend | 245 | en_US |
item.fulltext | no fulltext | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
item.openairetype | journal article | - |
item.grantfulltext | none | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Surgery | - |
crisitem.author.orcid | 0000-0002-6557-211X | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。